Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Human Angiotensin Receptor Subtypes.

R. Smith, P. Timmermans
Published 1994 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The rapid expansion of our knowledge of angiotensin receptors has been led by the development of subtype-specific angiotensin II receptor antagonists and by the cloning and sequencing of the AT1 receptor in angiotensin II. Although some actions of angiotensin II have been attributed to AT2 subtype receptors, the importance of these binding sites remains elusive. Nonpeptide, AT1-selective antagonists, such as losartan, block virtually all of the well-known effects of angiotensin II in mammalian cells. The effects of losartan are now being confirmed by the rapidly developing class of nonpeptide, AT1-selective angiotensin II receptor antagonists. In rodents, subtypes of the AT1 receptor have been cloned and designated AT1A and AT1B, but they have not been functionally distinguished. Such isoforms have not been identified for human AT1 receptors. Importantly, it now appears that the AT2 receptor has been cloned. The angiotensin receptors undergoing intense study are those in fetal tissue, brain, endothelial cells, and fibroblasts. Angiotensin II-induced growth and cardiovascular hypertrophy are the focus of broad-based research efforts. The clinical relevance of angiotensin II receptor subtypes is unknown, but there is growing evidence that AT1-selective agents are effective inhibitors of the angiotensin system in humans.



This paper is referenced by
10.1021/ci400400m
Ligand Binding Determinants for Angiotensin II Type 1 Receptor from Computer Simulations
Minos-Timotheos Matsoukas (2013)
10.1046/j.1524-475X.1996.40313.x
Alterations of angiotensin II receptor levels in full‐thickness excisional wounds in rat skin
M. Abiko (1996)
10.1007/978-3-0348-7579-0_2
Genetics of the renin-angiotensin-aldosterone system and risk of arterial disease
M. Lajemi (2001)
10.1016/S0140-6736(99)10365-9
Angiotensin II receptor antagonists
M. Burnier (2000)
10.1002/0471141755.ph0110s01
Characterization of Angiotensin II Receptors
R. Smith (1998)
10.1517/13543784.6.5.489
Angiotensin II receptor antagonists - antihypertensive agents.
M. Burnier (1997)
10.1177/44.5.8627002
Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice.
S. Mentzel (1996)
10.1016/S0895-7061(99)00103-X
The renin-angiotensin-aldosterone system: a specific target for hypertension management.
M. Weir (1999)
10.1016/S0143-4004(96)80007-5
High densities of angiotensin II subtype 2 (AT2) receptors in the porcine placenta and fetal membranes.
A. Nielsen (1996)
Angiotensin II induced inflammation and vascular dysfunction : Role of oxidative stress and cyclooxygenase
Zhongjian Cheng (2002)
10.1038/sj.bjp.0701437
Imbalance between the endothelial cell‐derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis
S. Schuller-Petrovic (1997)
10.1016/S0140-6736(05)74874-1
New drug classes
D. Sharp (1999)
10.1016/J.LFS.2007.06.007
An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
G. K. Aulakh (2007)
10.1016/S1889-1837(01)71133-6
Papel de los antagonistas de los receptores de la angiotensina II en la insuficiencia cardíaca
V. B. Alonso (2001)
10.1161/01.HYP.30.3.337
Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats: effect of ACE inhibition.
F. Amiri (1997)
10.1007/s003600050139
Effects of ANG II and III and angiotensin receptor blockers on nasal salt gland secretion and arterial blood pressure in conscious Pekin ducks (Anas platyrhynchos)
D. Butler (1998)
10.1016/S0083-6729(00)60021-3
Angiotensin II and calcium channels.
M. Rossier (2000)
10.1152/ajpheart.00723.2018
The renin-angiotensin system: going beyond the classical paradigms
R. Santos (2019)
10.2218/gtopdb/f6/2019.4
Angiotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
W. Alexander (2019)
10.2165/00003495-199856050-00013
Candesartan Cilexetil
Karen J. McClellan (2012)
10.1007/BF00126376
Prevention of ventricular remodeling after myocardial infarction and in congestive heart failure
B. Jugdutt (2004)
10.1016/S0140-6736(99)10365-9
Angiotensin ii receptor antagonists
Philip C. Carpino (2000)
10.1007/978-3-642-79645-6_1
Angiotensin-II-Rezeptoren: Physiologische und pharmakologische Bedeutung
P. Timmermans (1996)
Mouse glomerular epithelial cells in culture with features of podocytes in vivo express aminopeptidase A and angiotensinogen but not other components of the renin-angiotensin system.
S. Mentzel (1997)
10.1097/00004872-200018030-00005
Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene
X. Zhang (2000)
10.1038/4475
DNA microarrays in drug discovery and development
C. Debouck (1999)
10.1152/AJPHEART.00046.2003
Angiotensin II mediates uterine vasoconstriction through α-stimulation
B. Cox (2004)
10.1007/978-3-642-18497-0_14
Angiotensin and Aldosterone Biosynthesis
A. Capponi (2004)
Semantic Scholar Logo Some data provided by SemanticScholar